FDA approval Ketoconazole - Nizoral clinical trails
Home       Treatment        Side Effects       Janssen       FDA Aproval

 

FDA approval for Ketoconazole - Nizoral

The ketoconazole is used to treat the fungal infections mainly affecting the skins and ketoconazlole is the generic name of this medicine and brand name of this drug is Nizoral. The ketaconazole is having different products including ketoconazole tablets, ketoconazole shampoo and ketoconazole cream. Ketoconazole was approved in June 15 in 1999 by FDA or Food and Drug Administration which is situated in United States of America . FDA application number of this medicine is 074971 and ketoconazole is containing active ingredient named ketoconazole.

The FDA approved this medicine for a company named Novopharm NC, Inc and Novaphorm limited is the agent for this company. The Food and Drug Administration got application in September 30 in 1996 for the approval of this keoconazole and FDA had approximately taken three years for researches and clinical trials. The Food and Drug Administration has experienced that the Nizoral is safe to use and very effective to fungal infections and other skin diseases. Novopharm limited is situated in 5691 Main Street west, stouffville, Ontario, Canada.

This nizoral tablets is having 200mg manufactured by Janssen pharmaceutical. The Nizoral medicine is covered by U S patent and the expiry date of this patent on fifteenth June in 1999. So the Novopharm’s ketoconazole is available for sale after this patent. Nowadays, the doctors have prescribed this medicine for the treatment of many skin diseases and it will become one of the best antifungal drugs in nearest future.
 

Home       Treatment        Side Effects       Janssen       FDA Aproval